Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded the keyword 'Tenosynovial giant cell tumor, diffuse type' and a 'Genetic and Rare Diseases Information Center' resource to the study page.SummaryDifference0.1%

- Check16 days agoChange DetectedThe study's recruitment status was updated to Active, not Recruiting, and the record shows Revision: v3.5.0 with recent update dates.SummaryDifference1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded site revision tag 'Revision: v3.4.2'. Deleted items include a funding-status notice and the earlier 'Revision: v3.4.1' notice.SummaryDifference0.4%

- Check66 days agoChange DetectedAdded a government funding notice at the top of the page and updated site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe page adds a glossary toggle and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revised capitalization, and updates the revision to v3.4.0, replacing the previous v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.